These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22819499)

  • 101. [Preparation and in-vitro degradation of polylactide and poly(L-lactide-co-glycolide)].
    Wei Z; Liu L; Zhang M; Yang F; Qi M
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Feb; 25(1):122-6. PubMed ID: 18435272
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Macromolecule release from monodisperse PLG microspheres: control of release rates and investigation of release mechanism.
    Berkland C; Pollauf E; Raman C; Silverman R; Kim K'; Pack DW
    J Pharm Sci; 2007 May; 96(5):1176-91. PubMed ID: 17455338
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Biodegradable poly(DL-lactic-co-glycolic acid) microspheres containing tetracaine hydrochloride. In-vitro release profile.
    Ramirez L; Pastoriza P; Herrero-Vanrell R
    J Microencapsul; 1999; 16(1):105-15. PubMed ID: 9972507
    [TBL] [Abstract][Full Text] [Related]  

  • 104. A biodegradable polymeric system for peptide-protein delivery assembled with porous microspheres and nanoparticles, using an adsorption/infiltration process.
    Alcalá-Alcalá S; Urbán-Morlán Z; Aguilar-Rosas I; Quintanar-Guerrero D
    Int J Nanomedicine; 2013; 8():2141-51. PubMed ID: 23788833
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Nanoscaled buffering zone of charged (PLGA)n-b-bPEI micelles in acidic microclimate for potential protein delivery application.
    Kang HC; Lee JE; Bae YH
    J Control Release; 2012 Jun; 160(3):440-50. PubMed ID: 22405902
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Influence of lactide vs glycolide composition of poly (lactic-co-glycolic acid) polymers on encapsulation of hydrophobic molecules: molecular dynamics and formulation studies.
    Dobhal A; Srivastav A; Dandekar P; Jain R
    J Mater Sci Mater Med; 2021 Sep; 32(10):126. PubMed ID: 34591178
    [TBL] [Abstract][Full Text] [Related]  

  • 107. The effect of temozolomide/poly(lactide-co-glycolide) (PLGA)/nano-hydroxyapatite microspheres on glioma U87 cells behavior.
    Zhang D; Tian A; Xue X; Wang M; Qiu B; Wu A
    Int J Mol Sci; 2012; 13(1):1109-1125. PubMed ID: 22312307
    [TBL] [Abstract][Full Text] [Related]  

  • 108. A short term quality control tool for biodegradable microspheres.
    D'Souza S; Faraj JA; Dorati R; DeLuca PP
    AAPS PharmSciTech; 2014 Jun; 15(3):530-41. PubMed ID: 24519488
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Formation of acylated growth hormone-releasing peptide-6 by poly(lactide-co-glycolide) and its biological activity.
    Na DH; Lee JE; Jang SW; Lee KC
    AAPS PharmSciTech; 2007 Jun; 8(2):Article 43. PubMed ID: 17622118
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Combinatorial co-encapsulation of hydrophobic molecules in poly(lactide-co-glycolide) microparticles.
    Acharya AP; Lewis JS; Keselowsky BG
    Biomaterials; 2013 Apr; 34(13):3422-30. PubMed ID: 23375950
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Accelerated in vitro release testing of implantable PLGA microsphere/PVA hydrogel composite coatings.
    Shen J; Burgess DJ
    Int J Pharm; 2012 Jan; 422(1-2):341-8. PubMed ID: 22016033
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Acidic nanoparticles are trafficked to lysosomes and restore an acidic lysosomal pH and degradative function to compromised ARPE-19 cells.
    Baltazar GC; Guha S; Lu W; Lim J; Boesze-Battaglia K; Laties AM; Tyagi P; Kompella UB; Mitchell CH
    PLoS One; 2012; 7(12):e49635. PubMed ID: 23272048
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Studies on in vitro availability, degradation, and thermal properties of naltrexone-loaded biodegradable microspheres.
    Akala EO; Wiriyacoonkasem P; Pan G
    Drug Dev Ind Pharm; 2011 Jun; 37(6):673-84. PubMed ID: 21449706
    [TBL] [Abstract][Full Text] [Related]  

  • 114. PLGA Microspheres Containing Hydrophobically Modified Magnesium Hydroxide Particles for Acid Neutralization-Mediated Anti-Inflammation.
    Kim JK; Go EJ; Ko KW; Oh HJ; Han J; Han DK; Park W
    Tissue Eng Regen Med; 2021 Aug; 18(4):613-622. PubMed ID: 33877618
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Magnetic poly(lactide-co-glycolide) and cellulose particles for MRI-based cell tracking.
    Nkansah MK; Thakral D; Shapiro EM
    Magn Reson Med; 2011 Jun; 65(6):1776-85. PubMed ID: 21404328
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Modulating beta-lapachone release from polymer millirods through cyclodextrin complexation.
    Wang F; Blanco E; Ai H; Boothman DA; Gao J
    J Pharm Sci; 2006 Oct; 95(10):2309-19. PubMed ID: 16883563
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Accelerating protein release from microparticles for regenerative medicine applications.
    White LJ; Kirby GT; Cox HC; Qodratnama R; Qutachi O; Rose FR; Shakesheff KM
    Mater Sci Eng C Mater Biol Appl; 2013 Jul; 33(5):2578-83. PubMed ID: 23623071
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Multimodal delivery of irinotecan from microparticles with two distinct compartments.
    Rahmani S; Park TH; Dishman AF; Lahann J
    J Control Release; 2013 Nov; 172(1):239-245. PubMed ID: 23973814
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Redefining the importance of polylactide-co-glycolide acid (PLGA) in drug delivery.
    Chavan YR; Tambe SM; Jain DD; Khairnar SV; Amin PD
    Ann Pharm Fr; 2022 Sep; 80(5):603-616. PubMed ID: 34896382
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Biocompatibility and biodegradation studies of subconjunctival implants in rabbit eyes.
    Peng Y; Ang M; Foo S; Lee WS; Ma Z; Venkatraman SS; Wong TT
    PLoS One; 2011; 6(7):e22507. PubMed ID: 21799878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.